[1]
Hanumant Gambhire, Monica Gulati, Sachin Kumar Singh, Atul Nasa, and Neelu Goel, “AN OVERVIEW OF US FDA WARNING LETTERS TO INDIAN PHARMACEUTICAL INDUSTRIES FOR cGMP VIOLATIONS PERTAINING TO STERILE PRODUCTS”, J Popl Ther Clin Pharmacol, vol. 29, no. 03, pp. 1845–1863, Aug. 2022, doi: 10.53555/jptcp.v29i03.7242.